CORN SILK (STIGMA MAYDIS) EXTRACT SUCCESSFULLY REDUCES BLOOD GLUCOSE LEVELS IN ALLOXAN-INDUCED DIABETIC MICE
Erlisna, Rachel Indah Putri Ayu
ORCID: https://orcid.org/0009-0001-2297-5234, Said, Amanulloh Naufal, Mas'udah, Anni Fithriyatul
ORCID: https://orcid.org/0000-0002-9195-0188 and Mashudi, Sugeng
ORCID: https://orcid.org/0000-0003-3049-7014
(2026)
CORN SILK (STIGMA MAYDIS) EXTRACT SUCCESSFULLY REDUCES BLOOD GLUCOSE LEVELS IN ALLOXAN-INDUCED DIABETIC MICE.
Jurnal Penelitian Kesehatan Suara Forikes (Journal of Health Research Forikes Voice), 17 (3).
pp. 282-286.
ISSN 2502-7778
SURAT PERSETUJUAN UNGGAH KARYA_RACHEL INDAH PUTRI AYU ERLISNA_22632159.pdf
Download (240kB)
HALAMAN DEPAN_RACHEL INDAH PUTRI AYU ERLISNA.pdf
Download (1MB)
ARTIKEL JURNAL TERBIT_RACHEL INDAH PUTRI AYU ERLISNA_22632159.pdf
Download (118kB)
LAMPIRAN_RACHEL INDAH PUTRI AYU ERLISNA.pdf
Restricted to Repository staff only
Download (5MB)
22632159-RACHEL INDAH PUTRI AYU ERLISNA.pdf
Restricted to Repository staff only
Download (9MB)
Abstract
Type 2 diabetes mellitus (T2DM) is a chronic metabolic disorder that requires effective therapeutic strategies with minimal adverse effects. The search for complementary antidiabetic agents derived from natural products has gained increasing attention, particularly those with potential antihyperglycemic activity and favorable safety profiles. Corn silk (Stigma maydis) contains bioactive compounds reported to influence glucose metabolism, making it a promising candidate for adjunctive therapy in T2DM management. This study aimed to evaluate the antihyperglycemic effect of the optimal dose of Stigma maydis ethanol extract (P3) compared with metformin (positive control, K+) in alloxan-induced hyperglycemic male Swiss Webster mice. Male Swiss Webster mice were induced with alloxan at 150 mg/kgBW to establish a hyperglycemic model. The optimal dose of Stigma maydis extract (P3) and metformin (K+) were administered orally for 14 days. Blood glucose levels were measured before and after treatment. Paired t-tests were used to assess within-group changes, while independent t-tests were applied to compare post-treatment glucose levels between groups. The P3 group demonstrated a significant reduction in blood glucose levels (p = 0.003), with a post-treatment mean of 111.40 mg/dL. Although the numerical decrease in the P3 group exceeded that of the metformin group, the difference between groups was not statistically significant (p = 0.576). These findings indicate that the antihyperglycemic activity of Stigma maydis extract is statistically comparable to metformin under the experimental conditions tested. In conclusion, the optimal dose of Stigma maydis ethanol extract produced a significant antihyperglycemic effect in alloxan-induced mice, with efficacy comparable to metformin. These results support the potential of Stigma maydis as a complementary therapeutic option for T2DM management, warranting further investigation in larger preclinical and clinical studies.
Keywords: Stigma maydis; metformin; antihyperglycemic activity
| Dosen Pembimbing: | Mashudi, Sugeng and Mas'udah, Anni Fithriyatul | 0731038002, 0715049002 |
|---|---|
| Item Type: | Article |
| Additional Information: | This article is an output of the Program Kreativitas Mahasiswa – Riset Eksakta (PKM-RE) funded by Kemendikbudristek (Ditjen Belmawa). |
| Uncontrolled Keywords: | Keywords: Stigma maydis; metformin; antihyperglycemic activity |
| Subjects: | R Medicine > RM Therapeutics. Pharmacology |
| Divisions: | Faculty of Health Sciences > Departement of Nursing S1 |
| Depositing User: | Rachel Indah Putri Ayu Erlisna |
| Date Deposited: | 03 Aug 2026 07:53 |
| Last Modified: | 03 Aug 2026 07:53 |
| URI: | https://eprints.umpo.ac.id/id/eprint/19630 |
